1660 related articles for article (PubMed ID: 26051999)
1. Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?
Telli O; Samancı C; Sarıcı H; Hascıcek AM; Kabar M; Eroglu M
J Pediatr Urol; 2015 Oct; 11(5):265.e1-5. PubMed ID: 26051999
[TBL] [Abstract][Full Text] [Related]
2. Monosymptomatic and non-monosymptomatic nocturnal enuresis: a clinical evaluation.
Naseri M; Hiradfar M
Arch Iran Med; 2012 Nov; 15(11):702-6. PubMed ID: 23102248
[TBL] [Abstract][Full Text] [Related]
3. Could urinary nerve growth factor and bladder wall thickness predict the treatment outcome of children with overactive bladder?
Huseynov A; Telli O; Haciyev P; Okutucu TM; Akinci A; Ozkidik M; Erguder I; Fitoz S; Burgu B; Soygur T
Int Braz J Urol; 2022; 48(3):553-560. PubMed ID: 35373950
[TBL] [Abstract][Full Text] [Related]
4. Bladder wall thickness and urodynamic correlation in children with primary nocturnal enuresis.
Charalampous S; Printza N; Hashim H; Bantouraki M; Rompis V; Ioannidis E; Papacristou F
J Pediatr Urol; 2013 Jun; 9(3):334-8. PubMed ID: 22652388
[TBL] [Abstract][Full Text] [Related]
5. BDNF and NGF gene polymorphisms and urine BDNF-NGF levels in children with primary monosymptomatic nocturnal enuresis.
Ece A; Coşkun S; Şahin C; Tan I; Karabel D; Çim A
J Pediatr Urol; 2019 May; 15(3):255.e1-255.e7. PubMed ID: 30981636
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound bladder measurements in children with severe primary nocturnal enuresis: pretreatment and posttreatment evaluation and its correlation with treatment outcome.
Sreedhar B; Yeung CK; Leung VY; Chu CW
J Urol; 2008 Apr; 179(4):1568-72; discussion 1572. PubMed ID: 18295261
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonographic bladder measurements can replace urodynamic study for the diagnosis of non-monosymptomatic nocturnal enuresis.
Tafuro L; Montaldo P; Iervolino LR; Cioce F; del Gado R
BJU Int; 2010 Jan; 105(1):108-11. PubMed ID: 19583728
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological functioning related to specific characteristics of nocturnal enuresis.
Van Herzeele C; Dhondt K; Roels SP; Raes A; Groen LA; Hoebeke P; Walle JV
J Pediatr Urol; 2015 Aug; 11(4):208.e1-6. PubMed ID: 26206411
[TBL] [Abstract][Full Text] [Related]
9. Is routine urinary tract investigation necessary for children with monosymptomatic primary nocturnal enuresis?
Cayan S; Doruk E; Bozlu M; Akbay E; Apaydin D; Ulusoy E; Canpolat B
Urology; 2001 Oct; 58(4):598-602. PubMed ID: 11597547
[TBL] [Abstract][Full Text] [Related]
10. [Nocturnal enuresis in children--how to diagnose, how to treat?].
Paruszkiewicz G
Wiad Lek; 2013; 66(1):35-44. PubMed ID: 23905426
[TBL] [Abstract][Full Text] [Related]
11. Predictors of outcome in children and adolescents with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation.
Hoffmann A; Sampaio C; Nascimento AA; Veiga ML; Barroso U
J Pediatr Urol; 2018 Feb; 14(1):54.e1-54.e6. PubMed ID: 28974365
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bladder capacity in children with lower urinary tract symptoms: Comparison of 48-hour frequency/volume charts and uroflowmetry measurements.
Maternik M; Chudzik I; Krzeminska K; Żurowska A
J Pediatr Urol; 2016 Aug; 12(4):214.e1-5. PubMed ID: 27329866
[TBL] [Abstract][Full Text] [Related]
13. Predictors of severity and treatment response in children with monosymptomatic nocturnal enuresis receiving behavioral therapy.
Elsayed ER; Abdalla MM; Eladl M; Gabr A; Siam AG; Abdelrahman HM
J Pediatr Urol; 2012 Feb; 8(1):29-34. PubMed ID: 21296023
[TBL] [Abstract][Full Text] [Related]
14. Assessment of serum levels of copeptin and corticotropin-releasing factor in children with monosymptomatic and non-monosymptomatic nocturnal enuresis.
Girisgen I; Avcı E; Yüksel S
J Pediatr Urol; 2019 Aug; 15(4):393-398. PubMed ID: 31256952
[TBL] [Abstract][Full Text] [Related]
15. Evidence of reduced bladder capacity during nighttime in children with monosymptomatic nocturnal enuresis.
Borg B; Kamperis K; Olsen LH; Rittig S
J Pediatr Urol; 2018 Apr; 14(2):160.e1-160.e6. PubMed ID: 29174376
[TBL] [Abstract][Full Text] [Related]
16. Urinary nerve growth factor can predict therapeutic efficacy in children with monosymptomatic nocturnal enuresis.
Morizawa Y; Aoki K; Iemura Y; Hori S; Gotoh D; Fukui S; Nakai Y; Miyake M; Torimoto K; Tanaka N; Fujimoto K
Neurourol Urodyn; 2019 Nov; 38(8):2311-2317. PubMed ID: 31432572
[TBL] [Abstract][Full Text] [Related]
17. Postvoidal residual urine is the most significant non-invasive diagnostic test to predict the treatment outcome in children with non-neurogenic lower urinary tract dysfunction.
Beksac AT; Koni A; Bozacı AC; Dogan HS; Tekgul S
J Pediatr Urol; 2016 Aug; 12(4):215.e1-8. PubMed ID: 27233211
[TBL] [Abstract][Full Text] [Related]
18. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
[TBL] [Abstract][Full Text] [Related]
19. Clinical inconsistency of lower urinary tract symptoms between questionnaire and bladder diary in children with nocturnal enuresis.
Kwak KW; Park KH
J Urol; 2008 Sep; 180(3):1085-9; discussion 1089-90. PubMed ID: 18639291
[TBL] [Abstract][Full Text] [Related]
20. Enuresis and overactive bladder in children: what is the relationship between these two conditions?
Sousa AS; Veiga ML; Braga AA; Carvalho MC; Barroso U
Int Braz J Urol; 2016; 42(4):798-802. PubMed ID: 27564293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
